4//SEC Filing
Peterson Amy C. 4
Accession 0001140361-23-012614
CIK 0001501989other
Filed
Mar 19, 8:00 PM ET
Accepted
Mar 20, 6:43 PM ET
Size
4.6 KB
Accession
0001140361-23-012614
Insider Transaction Report
Form 4
Peterson Amy C.
EVP, Chief Development Officer
Transactions
- Sale
Common Stock
2023-03-16$1.98/sh−4,257$8,425→ 58,433 total
Footnotes (2)
- [F1]The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of restricted stock units.
- [F2]Includes 30,000 restricted stock units.
Documents
Issuer
CytomX Therapeutics, Inc.
CIK 0001501989
Entity typeother
Related Parties
1- filerCIK 0001682735
Filing Metadata
- Form type
- 4
- Filed
- Mar 19, 8:00 PM ET
- Accepted
- Mar 20, 6:43 PM ET
- Size
- 4.6 KB